Thomas Richard Fleming

Thomas Richard Fleming is a Professor of Biostatistics and Statistics at the University of Washington’s School of Public Health. He holds dual appointments in the Department of Biostatistics and the Department of Statistics. His research focuses on clinical trial methodology, survival analysis, sequential analysis, and applications in HIV/AIDS and cancer research. Dr. Fleming has authored over 250 peer-reviewed articles and served as a leader on over 100 clinical trials, including pivotal studies like HIVNET 012 and HPTN 052. He is a member of the National Academy of Medicine and recipient of the 2020 Ward Cates Spirit Award for contributions to HIV prevention research. His work emphasizes rigorous statistical design and ethical oversight of clinical trials.

• Education:
• PhD in Statistics, University of Maryland (1976)
• MA in Statistics, University of Maryland (1974)
• BA in Mathematics, College of St. Thomas (1972)
• Affiliations:
• Member, FDA Advisory Committees
• Former Principal Investigator for HPTN/SDMC/FHCRC (1994–2000)
• Chair/Elected Member on numerous data monitoring committees

His research interests span advanced statistical methods for clinical trials, including sequential analysis and survival modeling. He has pioneered methodologies to optimize trial efficiency while maintaining ethical and safety standards. Fleming’s work on HIV prevention and treatment trials has significantly influenced global public health policies.

Dr. Fleming’s scientific contributions include foundational studies on antiretroviral therapy efficacy and vaccine trial design. He advocates for transparent, globally equitable research practices and has mentored numerous students and researchers in biostatistical methods. His recent focus on pandemic response strategies underscores his commitment to addressing urgent public health challenges.